Switching From an LHRH Antagonist to an LHRH Agonist: A Case Report of 10 Finnish Patients With Advanced Prostate Cancer

Oncology and Therapy - Switzerland
doi 10.1007/s40487-017-0040-8
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comparison of Serum Testosterone Levels in Prostate Cancer Patients Receiving LHRH Agonist Therapy With or Without the Removal of the Prostate

Journal of the Canadian Urological Association
OncologyUrology
2012English

ADRENARCHE AND GROWTH DURING LHRH AGONIST (LHRHa) ADMINISTRATION

Pediatric Research
Child HealthPediatricsPerinatology
1984English

LHRH Et Agonistes

Medecine/Sciences
BiochemistryMedicineGeneticsMolecular Biology
1985English

Clinical Significance of Suboptimal Hormonal Levels in Men With Prostate Cancer Treated With LHRH Agonists

Canadian Urological Association Journal
Urology
2013English

Degarelix Monotherapy Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Agonists Plus Anti-Androgen Flare Protection in Advanced Prostate Cancer: An Analysis of Two Randomized Controlled Trials

Therapeutic Advances in Urology
Urology
2015English

Antiandrogènes Et Agonistes De LHRH Dans Le Traitement Du Cancer De La Prostate

Medecine/Sciences
BiochemistryMedicineGeneticsMolecular Biology
1985English

Long-Term Reversible Suppression of Oestrus in Bitches With Nafarelin Acetate, a Potent LHRH Agonist

Reproduction
Cell BiologyGynecologyEndocrinologyReproductive MedicineObstetricsEmbryology
1985English

LHRH-Therapie: Testosteronwerte Regelmäßig Überprüfen!

Uro-News
2012English

EP-100 + Paclitaxel to Overcome Taxane Resistance in Patients With Recurrent LHRH-receptor Expressing Ovarian Cancer.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy